Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rest-activity patterns across development in two mouse models of autism and epilepsy.

Epilepsia open·2026
Same author

Gene therapy for epilepsy: An emerging, promising approach for a serious neurological disorder.

Journal of internal medicine·2025
Same author

Dose-Dependent Effects of Myo-Inositol on Kainic Acid-Induced Epilepsy: Electrophysiological, Behavioral, Transcriptomic, and DNA Methylome Studies.

International journal of molecular sciences·2025
Same author

Modulation of epileptogenesis through transplantation of human mesenchymal stem cells with or without GDNF release.

Cellular and molecular life sciences : CMLS·2025
Same author

AAV-mediated gene therapy for focal epilepsy by expressing neuropeptide Y and Y2 receptor in rodent and non-human primate hippocampus.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

An interview with Thomas Foutz, 2025 Epilepsia open prize winner for basic science research.

Epilepsia open·2025
Same journal

Alcohol-fluoxetine co-treatment drives gut dysbiosis and intestinal barrier disruption with consequences for neuroimmune signaling in male rats.

Neuropharmacology·2026
Same journal

Thyrotropin-releasing hormone and dopaminergic systems interact in the ventral tegmental area to regulate food intake in rats.

Neuropharmacology·2026
Same journal

TRPC5 as a modulator of TRPV1 signalling in pathological pain states.

Neuropharmacology·2026
Same journal

Loss of mGlu<sub>5</sub> receptors from PV inhibitory neurons attenuates sex differences in ethanol and sucrose seeking.

Neuropharmacology·2026
Same journal

PM289, a synthetic CB2 in vitro receptor agonist, modulates morphine-induced antinociceptive effect and withdrawal syndrome in an animal model of osteoarthritic pain.

Neuropharmacology·2026
Same journal

Purinergic-cytokine signaling as a regulatory axis in neuroimmune development.

Neuropharmacology·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

An Integrated Method for Crafting Flexible and Convenient Electrophysiological Optrodes for Multi-Region In Vivo Recording
06:55

An Integrated Method for Crafting Flexible and Convenient Electrophysiological Optrodes for Multi-Region In Vivo Recording

Published on: November 21, 2024

An optogenetic approach in epilepsy.

Merab Kokaia1, My Andersson, Marco Ledri

  • 1Experimental Epilepsy Group, Wallenberg Neuroscience Center, Lund University Hospital, Sölvegatan 17, BMC A11, 22184 Lund, Sweden. Merab.Kokaia@med.lu.se

Neuropharmacology
|June 16, 2012
PubMed
Summary
This summary is machine-generated.

Optogenetics uses light-sensitive proteins to control neuronal excitability, offering new epilepsy treatment strategies. This review summarizes optogenetic advances in epilepsy research and future therapeutic potential.

More Related Videos

A Method for High Fidelity Optogenetic Control of Individual Pyramidal Neurons In vivo
13:44

A Method for High Fidelity Optogenetic Control of Individual Pyramidal Neurons In vivo

Published on: September 2, 2013

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
09:43

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Published on: October 5, 2021

Related Experiment Videos

Last Updated: May 21, 2026

An Integrated Method for Crafting Flexible and Convenient Electrophysiological Optrodes for Multi-Region In Vivo Recording
06:55

An Integrated Method for Crafting Flexible and Convenient Electrophysiological Optrodes for Multi-Region In Vivo Recording

Published on: November 21, 2024

A Method for High Fidelity Optogenetic Control of Individual Pyramidal Neurons In vivo
13:44

A Method for High Fidelity Optogenetic Control of Individual Pyramidal Neurons In vivo

Published on: September 2, 2013

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
09:43

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Published on: October 5, 2021

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biotechnology

Background:

  • Optogenetics utilizes light-sensitive proteins to modulate neuronal activity.
  • Two classes of tools enable neuronal depolarization or hyperpolarization, controlling action potentials.
  • This technology offers novel approaches for studying brain function and disease.

Purpose of the Study:

  • To review the current applications of optogenetics in epilepsy research.
  • To discuss future therapeutic strategies for brain diseases, particularly epilepsy.
  • To highlight challenges and potential pitfalls of using optogenetics for network excitability control.

Main Methods:

  • Expression of light-sensitive proteins (e.g., halorhodopsin NpHR) in mammalian neurons.
  • Utilizing optogenetic tools to control neuronal excitability in experimental models.
  • Reviewing existing literature on optogenetics in epilepsy.

Main Results:

  • Optogenetics has shown efficacy in controlling chemically and electrically induced epileptiform activity.
  • Halorhodopsin NpHR expression in hippocampal cells reduced seizure activity in slice preparations.
  • Optogenetics successfully reduced in vivo neuronal spiking in motor cortex models.

Conclusions:

  • Optogenetics presents a promising avenue for understanding and treating epilepsy.
  • Future research should focus on optimizing optogenetic tools for clinical application in neurological disorders.
  • Careful consideration of challenges is necessary for successful translation to therapeutic strategies.